Daily Stock Analysis, XPER, Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland., priceseries

Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.. Daily Stock Analysis
Stock Information
Open
16.58
Close
16.14
High
16.73
Low
16.09
Previous Close
16.57
Daily Price Gain
-0.43
YTD High
19.90
YTD High Date
Jan 5, 2022
YTD Low
15.72
YTD Low Date
Feb 24, 2022
YTD Price Change
-3.40
YTD Gain
-17.40%
52 Week High
24.84
52 Week High Date
Mar 18, 2021
52 Week Low
15.72
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-6.75
52 Week Gain
-29.49%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 6. 2016
34.59
Dec 30. 2016
38.08
17 Trading Days
10.09%
Link
LONG
Dec 13. 2017
20.52
Dec 27. 2017
21.96
9 Trading Days
7.01%
Link
LONG
Jan 4. 2019
18.06
Feb 8. 2019
19.88
24 Trading Days
10.09%
Link
LONG
Sep 4. 2019
17.87
Sep 20. 2019
18.93
12 Trading Days
5.97%
Link
LONG
Jul 20. 2020
13.96
Aug 6. 2020
16.91
13 Trading Days
21.08%
Link
LONG
Oct 6. 2020
11.59
Oct 15. 2020
12.22
7 Trading Days
5.48%
Link
LONG
Nov 5. 2020
13.29
Dec 14. 2020
18.90
26 Trading Days
42.28%
Link
Company Information
Stock Symbol
XPER
Exchange
NYSE
Company URL
http://www.dna.com
Company Phone
301-556-9809
CEO
Randal J. Kirk
Headquarters
Virginia
Business Address
1750 KRAFT DRIVE, SUITE 1400, BLACKSBURG, VA 24060
Sector
Intrexon Corporation has collaboration and license agreements with Ares Trading S.A.; ZIOPHARM Oncology, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; S & I Ophthalmic, LLC; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Thrive Agrobiotics, Inc.; Intrexon Energy Partners II, LLC; and others. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001356090
About

Description

Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform. It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; biological insect control solutions; technologies for non-browning apple without the use of any flavor-altering chemical or antioxidant additives; commercial aquaculture products; and artwork, children's toys, and novelty goods that are derived from living organisms or enabled by synthetic biology. The company serves health, food, energy, environment, and consumer sectors. Intrexon Corporation has collaboration and license agreements with Ares Trading S.A.; ZIOPHARM Oncology, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; S & I Ophthalmic, LLC; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Thrive Agrobiotics, Inc.; Intrexon Energy Partners II, LLC; and others. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.